← Back to Clinical Trials
Recruiting NCT07365098

NCT07365098 Liver Transplant Recipients and 30-Second Lie-to-Sit Test

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07365098
Status Recruiting
Phase
Sponsor Inonu University
Condition Liver Transplant Recipients
Study Type OBSERVATIONAL
Enrollment 34 participants
Start Date 2025-11-08
Primary Completion 2026-10-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
30-second lie-to-sit testModified Borg Scalewaist circumference

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 34 participants in total. It began in 2025-11-08 with a primary completion date of 2026-10-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to assess functional capacity in liver transplant recipients using the 30-second lie-to-sit test and to examine the relationships between functional capacity and variables such as muscle strength, upper and lower extremity function, exercise capacity, and perceived exertion.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18-65 years * Diagnosed with end-stage liver disease and listed for liver transplantation * Ability to speak, understand, and write in Turkish * No mental disorders * Voluntary participation with informed consent Exclusion Criteria: * Pulmonary, neurological, or cardiac diseases that may interfere with adherence to the assessment protocol * Difficulty complying with the assessment program * Musculoskeletal problems * History of regular physical activity * Multiple organ failure * Cognitive impairment

Contact & Investigator

Central Contact

Büşra CANDİRİ

✉ candiri_17@hotmail.com

📞 +905073780717

Frequently Asked Questions

Who can join the NCT07365098 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Liver Transplant Recipients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07365098 currently recruiting?

Yes, NCT07365098 is actively recruiting participants. Contact the research team at candiri_17@hotmail.com for enrollment information.

Where is the NCT07365098 trial being conducted?

This trial is being conducted at Malatya, Turkey (Türkiye).

Who is sponsoring the NCT07365098 clinical trial?

NCT07365098 is sponsored by Inonu University. The trial plans to enroll 34 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology